We conduct research to benefit people throughout their cancer journey – from prevention through treatment, survivorship support and palliative care. The School of Clinical Medicine’s research into cancer seeks to improve the outcome of high mortality cancers, for which current treatments are ineffective.
Our research benefits people at all stages of their cancer experience – from prevention through to treatment, with survivorship support and palliation. Our vision is to improve the lives of all people impacted by cancer by delivering evidence-based practice in diagnosis, intervention and support.
The Adult Cancer Program aims to increase collaboration and takes a multidisciplinary approach, developing novel ways to treat adult cancers.
We aim to improve outcomes in ovarian cancer, endometrial cancer and endometriosis.
We investigate the molecular pathways that transform healthy haematopoietic stem cells into leukaemic cells, as well as identifying the drivers behind treatment resistance.
We aim to improve ovarian cancer risk prediction and prognosis, by using large international consortia that are powered to have an impact for patients.
We’re focused on the pathogenesis and treatment of chronic pancreatitis and pancreatic cancer.
Collaboration for Cancer Outcomes Research and Evaluation (CCORE) aims to improve cancer outcomes through research by implementing best practice in the treatment of cancer.
The goal of the Medical Physics research group is to develop novel and impactful research to improve radiotherapy patient outcomes. This work is undertaken within the cancer therapy centres at Liverpool and Macarthur and other collaborating centres.
Our program brings together interdisciplinary expertise in cell & molecular biology, extracellular vesicle, multi-omics, radiation oncology, urological oncology, novel imaging modalities and clinical trials, to improve outcomes for cancer patients.